Safety of Manganese Restriction in Neonatal Parenteral Nutrition
Condition:   Infant, Newborn, Disease Interventions:   Other: Manganese omission;   Other: 5 mCg/kg/day manganese from " Multitrace-4 Neonatal. " Sponsors:   Sharp HealthCare;   Food and Drug Administration (FDA) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2020 Category: Research Source Type: clinical trials

Galera Therapeutics Announces Dosing of First Patient in Pivotal Phase 3 ‘ROMAN’ Clinical Trial of Avasopasem Manganese (GC4419)
MALVERN, Penn. — October 15, 2018 — Galera Therapeutics, Inc., a clinical-stage biotechnology company focused on the development of drugs targeting oxygen metabolic pathways with the potential to transform cancer radiotherapy, today announced... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - October 15, 2018 Category: Pharmaceuticals Source Type: clinical trials

Manganese-Enhanced Magnetic Resonance Imaging of the Myocardium
Conditions:   Ischemic Cardiomyopathy;   Dilated Cardiomyopathy;   Hypertrophic Cardiomyopathy Intervention:   Other: Mangafodipir trisodium Sponsor:   University of Edinburgh Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 31, 2018 Category: Research Source Type: clinical trials